Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

Phase 1

Recruiting

Conditions: High Grade Glioma
Glioblastoma

First Posted Date: 2022-10-04

Last Posted Date: 2025-06-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT05565118

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combin

Not Applicable

Recruiting

Conditions: Unintended Weight Loss

First Posted Date: 2022-08-01

Last Posted Date: 2025-06-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 1000

Registration Number: NCT05481697

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Cleveland African American Prostate Cancer Project

Not Applicable

Recruiting

Conditions: Prostate Cancer

First Posted Date: 2022-07-21

Last Posted Date: 2025-05-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 800

Registration Number: NCT05469269

Locations: 🇺🇸
Barbershops Local to Cleveland, Cleveland, Ohio, United States

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Withdrawn

Conditions: Colorectal Cancer
Rectal Cancer

First Posted Date: 2022-05-02

Last Posted Date: 2024-04-12

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT05356585

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Ductal Adenocarcinoma
Periampullary Cancer

Interventions: Other: Placebo
Drug: Escitalopram

First Posted Date: 2022-03-21

Last Posted Date: 2024-06-18

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 4

Registration Number: NCT05289830

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms

Not Applicable

Conditions: Periampullary Carcinoma
Pancreatic Neoplasms

First Posted Date: 2022-02-04

Last Posted Date: 2024-01-08

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT05225038

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Phase 1

Recruiting

Conditions: Relapsed Sarcomas

Interventions: Drug: Disulfiram
Drug: Copper Gluconate
Drug: Liposomal Doxorubicin (Doxil)

First Posted Date: 2022-01-27

Last Posted Date: 2025-03-25

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 24

Registration Number: NCT05210374

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma

Phase 1

Suspended

Conditions: Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Cancer

Interventions: Drug: Ivosidenib
Drug: mFOLFIRINOX

First Posted Date: 2022-01-26

Last Posted Date: 2025-07-02

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 16

Registration Number: NCT05209074

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Not Applicable

Active, not recruiting

Conditions: Lung Cancer
Left Sided Breast Cancer

First Posted Date: 2021-12-02

Last Posted Date: 2025-04-29

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 8

Registration Number: NCT05142358

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Not Applicable

Withdrawn

Conditions: Cutaneous T-cell Lymphoma
Mycosis Fungoides of Skin (Diagnosis)
Non Hodgkin Lymphoma
Lymphomatoid Papulosis
Lymphoma, Large-Cell, Anaplastic
Lymphoma, Follicular

Interventions: Device: Med-Jet Injector
Drug: Triamcinolone Acetonide
Device: Conventional syringe
Drug: Bexarotene 1% Top Gel
Drug: Nitrogen Mustard

First Posted Date: 2021-11-03

Last Posted Date: 2025-06-12

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 22

Registration Number: NCT05106192

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy